H&R GmbH & Co. KGaA (ETR:2HRA)

Germany · Delayed Price · Currency is EUR

6.74

-0.16 (-2.32%)

Oct 16, 2026, 5:44 PM CET

Market Cap	250.87M +37.0%
Revenue (ttm)	1.30B -1.9%
Net Income	2.54M -67.7%
EPS	0.07 -67.7%
Shares Out	37.22M
PE Ratio	101.25
Forward PE	5.36
Dividend	0.10 (1.48%)
Ex-Dividend Date	May 28, 2025

Volume	3,655
Open	6.90
Previous Close	6.90
Day's Range	6.66 - 6.90
52-Week Range	3.91 - 7.60
Beta	0.36
Analysts	Strong Buy
Price Target	7.50 (+11.28%)
Earnings Date	Nov 13, 2026

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA engages in the production and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts worldwide. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment offers paraffins, white oils, plasticizers, base oils, lubricants, and other crude-oil based specialty products, as well as bitumen, feedstocks, and bunker fuel. The ChemPharm Sales segment provides paraffins, plasticizers, wax emulsions, and other crude-oil based specialty produ... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1919

Employees 1,688

Stock Exchange Deutsche Börse Xetra

Ticker Symbol 2HRA

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 2HRA stock is "Strong Buy." The 12-month stock price target is €7.50, which is an increase of 11.28% from the latest price.

Price Target

€7.50

(11.28% upside)

Analyst Consensus: Strong Buy

Stock Forecasts